Midostaurin

Midostaurin is a oral prescription medication used in the treatment of acute myeloid leukemiaA cancer affecting the cells that develop into white or red blood cells. Both of these cell types originate from stem cells in bone marrow. Red blood cells function to carry oxygen to our tissues and the white cells (leukocytes) are part of our immune system. The cancerous cells often accumulate in the blood. and is often used in conjunction with a variety of chemotherapyTreatment of cancer patients with anticancer drugs. Commonly called 'chemo'. These drugs work by attacking cell growth or division. Often these agents are used in combination to take advantage of their different modes of attack on cell division. treatments. Typically, patients are told to take Midostaurin twice a day, but this is up to the physician's discretion.1
Midostaurin is a proteinOne of the four basic types of biomolecule. Proteins are polymers made up of strings of amino acids. Proteins serve many functions in organisms including transport of molecules, structure, cell adhesion and as signaling molecules such as hormones. Many transcription factors, including p53 and Rb are proteins. kinaseAn enzyme that adds phosphate groups to another molecule. Many key proteins controlling gene expression are kinase targets. Addition of a phosphate group to a protein can alter the activity of the protein and are often used as molecular on/off switches. For example, the retinoblastoma tumor suppressor gene is 'off' when phosphate groups are added to the protein at specific locations. Removal of the phosphate groups turns the protein 'on'. Enzymes that remove phosphate groups are known as phosphatases. Note that all enzymes, regardless of function, end in ASE inhibitor used to treat acute myeloid leukemiaA cancer affecting the cells that develop into white or red blood cells. Both of these cell types originate from stem cells in bone marrow. Red blood cells function to carry oxygen to our tissues and the white cells (leukocytes) are part of our immune system. The cancerous cells often accumulate in the blood.. This drug works by preventing the transfer of phosphate to protein building cells. By altering the protein building capabilities of cancerous cells, Midostaurin helps limit the progression and spread of cancer cells.1
The most common side effects associated with the use of Midostaurin include: low white blood cell counts with fever, nausea, redness and sores, headache, bruising, high sugar levels and upper respiratory issues.1
It is important to alert your doctor if have heart or lung problems, are pregnant or plan to become pregnant, as these conditions can have an adverse effect in the use of Midostaurin. Also important to note are the issues that can occur in breastfeeding and fertility, which are further outlined on the manufacturers website.1
- 1.a. b. c. Treatment Information. (n.d.). Retrieved July 18, 2017, from https://www.us.rydapt.com/interested-in/treatment-information/?site=43700018488751000&source=01030&gclid=CIiampKXk9UCFSKNswodGb8INw&gclsrc=ds
- 2. FDA Approved Rydapt. (n.d.). Retrieved July 18, 2017, from https://www.us.rydapt.com/